FI109704B - CENP-B-epitooppi - Google Patents

CENP-B-epitooppi Download PDF

Info

Publication number
FI109704B
FI109704B FI930106A FI930106A FI109704B FI 109704 B FI109704 B FI 109704B FI 930106 A FI930106 A FI 930106A FI 930106 A FI930106 A FI 930106A FI 109704 B FI109704 B FI 109704B
Authority
FI
Finland
Prior art keywords
cenp
antigen
test
peptide
autoantibodies
Prior art date
Application number
FI930106A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI930106A0 (fi
FI930106A (fi
Inventor
Ronald Verheyen
Venrooij Waltherus Jacobus Van
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI930106A0 publication Critical patent/FI930106A0/fi
Publication of FI930106A publication Critical patent/FI930106A/fi
Application granted granted Critical
Publication of FI109704B publication Critical patent/FI109704B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lubricants (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
FI930106A 1992-01-13 1993-01-12 CENP-B-epitooppi FI109704B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92200065 1992-01-13
EP92200065 1992-01-13

Publications (3)

Publication Number Publication Date
FI930106A0 FI930106A0 (fi) 1993-01-12
FI930106A FI930106A (fi) 1993-07-14
FI109704B true FI109704B (fi) 2002-09-30

Family

ID=8210361

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930106A FI109704B (fi) 1992-01-13 1993-01-12 CENP-B-epitooppi

Country Status (12)

Country Link
EP (1) EP0552829B1 (ko)
JP (1) JPH05310790A (ko)
KR (1) KR100296198B1 (ko)
AT (1) ATE179183T1 (ko)
AU (1) AU664063B2 (ko)
CA (1) CA2087143A1 (ko)
DE (1) DE69324509T2 (ko)
DK (1) DK0552829T3 (ko)
ES (1) ES2132171T3 (ko)
FI (1) FI109704B (ko)
GR (1) GR3030727T3 (ko)
ZA (1) ZA93174B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900012B1 (en) 1997-06-03 2005-05-31 The University Of Chicago Plant artificial chromosome compositions and methods
US7119250B2 (en) 1997-06-03 2006-10-10 The University Of Chicago Plant centromere compositions
US7193128B2 (en) 1997-06-03 2007-03-20 Chromatin, Inc. Methods for generating or increasing revenues from crops
US7227057B2 (en) 1997-06-03 2007-06-05 Chromatin, Inc. Plant centromere compositions
US7235716B2 (en) 1997-06-03 2007-06-26 Chromatin, Inc. Plant centromere compositions
US6177254B1 (en) * 1998-12-15 2001-01-23 Jerome Bernard Rattner Nucleolus autoantigenic marker for systemic lupus erthyematosus
US7989202B1 (en) 1999-03-18 2011-08-02 The University Of Chicago Plant centromere compositions
CA2557644C (en) 2004-02-23 2016-05-24 Chromatin, Inc. Plants modified with mini-chromosomes
KR100693042B1 (ko) * 2004-11-10 2007-03-12 삼성전자주식회사 무선 전원 공급 장치 및 그 방법
EP2272968A3 (en) 2005-09-08 2011-08-31 Chromatin, Inc. Plants modified with mini-chromosomes
WO2008112972A2 (en) 2007-03-15 2008-09-18 Chromatin, Inc. Centromere sequences and minichromosomes
US9096909B2 (en) 2009-07-23 2015-08-04 Chromatin, Inc. Sorghum centromere sequences and minichromosomes
DE102009039705A1 (de) 2009-08-31 2011-04-07 Dr. Fooke Laboratorien Gmbh Peptide des CENP-A und ihre Verwendung
ES2395100B2 (es) * 2011-07-11 2013-09-13 Univ Cadiz Metodo de obtencion de datos utiles para el diagnostico diferencial de la esclerodermia.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091303A (en) * 1989-10-27 1992-02-25 The General Hospital Corporation Diagnosis of wegener's granulomatosis

Also Published As

Publication number Publication date
KR100296198B1 (ko) 2001-10-22
KR930016439A (ko) 1993-08-26
GR3030727T3 (en) 1999-11-30
DE69324509T2 (de) 1999-10-07
EP0552829B1 (en) 1999-04-21
ES2132171T3 (es) 1999-08-16
DK0552829T3 (da) 1999-10-25
FI930106A0 (fi) 1993-01-12
AU664063B2 (en) 1995-11-02
JPH05310790A (ja) 1993-11-22
AU3114993A (en) 1993-07-15
ATE179183T1 (de) 1999-05-15
CA2087143A1 (en) 1993-07-14
FI930106A (fi) 1993-07-14
DE69324509D1 (de) 1999-05-27
EP0552829A1 (en) 1993-07-28
ZA93174B (en) 1993-08-13

Similar Documents

Publication Publication Date Title
FI109704B (fi) CENP-B-epitooppi
Surh et al. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope (s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex
JP2624973B2 (ja) エプスタイン・バーウイルス初期抗原（拡散）に関連する合成ポリペプチドおよび抗体
Božič et al. Sera from patients with rheumatic diseases recognize different epitope regions on the 52‐kD Ro/SS‐A protein
EP0445423A2 (en) Hepatitis C assay
US5457029A (en) Nuclear antigen La
EP2588495B1 (en) Histone citrullinated peptides and uses thereof
Gohill et al. Antibodies in procainamide-induced and systemic lupus erythematosus bind the C-terminus of histone 1 (H1)
EP0640101B1 (en) Methods and reagents for diagnosis of autoantibodies
US5945105A (en) Peptides of the antigen Sm-D and their use, in particular for the diagnostics of systemic lupus erythematosus (SLE)
JPH09308490A (ja) 原発性胆汁肝硬変自己抗原
WO2012160127A1 (en) Method for the diagnosis of rheumatoid arthritis
PT676965E (pt) Método para reduzir a imunogenicidade da região variável de anticorpos
JPH02502632A (ja) 新規ポリペプチド及びその用途
JP2021098746A (ja) 遺伝子組み換えトリパノソーマ・クルージｊｌ７抗原変異型およびシャーガス病を検出するためのその使用
JP5676263B2 (ja) バベシア・ミクロチ（Ｂａｂｅｓｉａ ｍｉｃｒｏｔｉ）に対する抗体を検出するための組成物及びその使用の方法
Muro et al. A charged segment mainly composed of basic amino acids forms an autoepitope of CENP-A
JP3176570B2 (ja) Ｈｃｖの検出又は測定方法
US11492381B2 (en) Quantitative enzyme-linked immunoassay (ELISA) to approximate complement fixing antibody titers in serum from patients with coccidioidomycosis
Kania et al. The isolation, detection, and cross-reactivity in Asian elephant IgG for the development of serological diagnostic tests.
JP3327549B2 (ja) Ｃ１００領域に対する組換え抗原を利用したｃ型肝炎アッセイ
FI104219B (fi) Diagnostinen menetelmä ja testaustarvikesarja multippeliskleroosin määrittämiseksi
WO2000047613A1 (fr) Proteine a membrane externe modifiee de treponema pallidum, son utilisation comme analyse immunologique et jeu d'analyse immunologique
JPH06207941A (ja) 非ａ非ｂ型肝炎の検査方法
JP2001224371A (ja) Ｈｃｖの検出又は測定方法

Legal Events

Date Code Title Description
MM Patent lapsed